Michael Cooper

Michael Cooper is an experienced executive in the healthcare industry, currently serving as Chief Executive Officer at the American Rheumatology Network since December 2020 and as Principal at Bell Curve Innovations since February 2019. Previously, Michael held the position of CEO and Chief Strategic Officer at Metro Medical from April 2015 to November 2018, where responsibilities included P&L management and driving specialty sales across various medical fields. Michael also served as President at Metro Medical from 2004 to 2013, focusing on pharmaceutical vendor relationships and expanding therapeutic areas. Earlier in the career, Michael was the National Sales Manager at Nextron/Haemotronic, where notable achievements included significant market growth in the Blood Plasma sector. Michael holds a Bachelor's degree from the University of Georgia.